0
     

Report Added
Report already added
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 - 2027)

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 - 2027)

The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to iIncreasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during the forecast period.

“High-level disinfectants and test stripsare expected to hold the largest share of the endoscope reprocessing market, by product in 2021.”

Based on product, the global endoscope reprocessing market is segmented into high-level disinfectants and test strips; detergents & wipes; endoscope tracking systems; endoscope drying, storage, and transport systems; automated endoscope reprocessors (AERs); and other products (brushes and flushing aids, leak testers, hookups, and sponges). In 2021, the high-level disinfectants and test strips segment holds the largest share of the global endoscope reprocessing market.

The large share of this segment is due to outbreak of infectious diseases to drive high-level disinfectants demand. Test strips are used to effectively measure the minimum recommended concentration of high-level disinfectants and provide fast disinfectant reaction time and a user-friendly color comparison chart to detect residual carbohydrate, protein, and hemoglobin to monitor the success of endoscope cleaning procedures.

“Hospitals are expected to hold the largest share of the endoscope reprocessing market, by end user in 2021.”

Based on end users, the global endoscope reprocessing market is segmented into hospitals, ambulatory surgery centers and clinics, and other end users (diagnostic centers, mobile endoscopy facilities, and office endoscopy centers). In 2021, the hospitals' segment has the largest share due to large patient volume in hospitals related to endoscopic procedures leads to increase demand for endoscope reprocessing products in hospitals.

“North America commanded the largest share of the endoscope reprocessing market in 2021.”

Based on region, the endoscope reprocessing market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2021, North America has the largest share of the endoscope reprocessing market. The largest share of North America can be attributed to factors such as the rising number of cancer cases, favorable reimbursement scenarios, and Increasing requirement for endoscopy to diagnose and treat target diseases.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (20%), Tier 2(45%), and Tier 3 (35%)
• By Designation: C-level Executives (30%), Directors (20%), and Others (50%)
• By Region: North America (33%), Europe (24%), AsiaPacific(27%), and Rest of the World (16%)

Some of the major players operating in this market areAdvanced Sterilization Products(US), Olympus Corporation (Japan), Ecolab(US), and STERIS(Ireland)

List of Companies Profiled in the Report
•Cantel Medical (US)
•Advanced Sterilization Products (ASP) (US)
•Olympus Corporation (Japan)
•Ecolab (US)
•STERIS (Ireland)
•Getinge AB (Sweden)
•Wassenburg Medical (Netherlands)
•CONMED Corporation (US)
•Belimed AG (Switzerland)
•Endo-Technik W. Griesat (Germany)
•Custom Ultrasonics (US)
•Steelco S.p.A. (Italy)
•BES Healthcare Ltd (UK)
•ARC Healthcare Solutions (Canada)
•Metrex Research, LLC. (Canada)
•Richard Wolf GmbH (Germany)
•MEDALKAN (Greece)
•Micro-Scientific, LLC (US)
•Borer Chemie AG (Switzerland)
•Tuttnauer (Netherlands)
•ATMS (Canada)
•Summit Imaging, Inc. (US)
•Medonica Co. LTD (South Korea)
•SHINVA MEDICAL INSTRUMENT CO. LTD (China)
•Medical Devices Group Srl (Italy)

Research Coverage
This report studies the endoscope reprocessing market based on product, end user, and region. The report also analyzes factors (such as drivers, restraints, challenges, and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total endoscope reprocessing market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
•Market Penetration: Comprehensive information on endoscope reprocessingoffered by the top 25 players in the endoscope reprocessing market. The report analyzes the endoscope reprocessing marketproduct, end user,and region.
•Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devicesacross key geographic regions.
•Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the endoscope reprocessing market
•Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the endoscope reprocessing market
Table of Contents

1INTRODUCTION33
1.1STUDY OBJECTIVES33
1.2MARKET DEFINITION33
1.2.1INCLUSIONS AND EXCLUSIONS33
1.3MARKET SCOPE34
1.3.1MARKET SEGMENTATION34
1.3.2GEOGRAPHIC SCOPE34
1.3.3YEARS CONSIDERED35
1.4CURRENCY35
1.5LIMITATIONS35
1.6STAKEHOLDERS36
1.7SUMMARY OF CHANGES36
2RESEARCH METHODOLOGY38
2.1RESEARCH DATA38
FIGURE 1RESEARCH DESIGN38
2.1.1SECONDARY DATA39
2.1.1.1Key data from secondary sources40
2.1.2PRIMARY DATA40
FIGURE 2PRIMARY SOURCES40
2.1.2.1Key data from primary sources41
2.1.2.2Key industry insights42
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND
DEMAND SIDE PARTICIPANTS42
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION43
2.2MARKET SIZE ESTIMATION43
FIGURE 5REVENUE SHARE ANALYSIS ILLUSTRATION: BELIMED AG
(A METALL ZUG GROUP COMPANY).44
FIGURE 6MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
(SUPPLY SIDE): COLLECTIVE REVENUE OF ENDOSCOPE REPROCESSING PRODUCTS AND SERVICES44
FIGURE 7CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS45
FIGURE 8TOP-DOWN APPROACH46
2.3MARKET BREAKDOWN AND DATA TRIANGULATION47
FIGURE 9DATA TRIANGULATION METHODOLOGY47
2.4STUDY ASSUMPTIONS48
2.5RISK ASSESSMENT/FACTOR ANALYSIS48
TABLE 1RISKS48

3EXECUTIVE SUMMARY49
FIGURE 10ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2022 VS. 2027 (USD BILLION)49
FIGURE 11ENDOSCOPE REPROCESSING MARKET, BY END-USER,
2022 VS. 2027 (USD BILLION)50
FIGURE 12ENDOSCOPE REPROCESSING MARKET, BY REGION,
2022 VS. 2027 (USD BILLION)51
4PREMIUM INSIGHTS52
4.1ENDOSCOPE REPROCESSING MARKET OVERVIEW52
FIGURE 13RISING INCIDENCE OF TARGET DISEASES AND SUBSEQUENT INCREASE IN ENDOSCOPIC PROCEDURES TO DRIVE MARKET GROWTH52
4.2ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET SHARE, BY PRODUCT (2021)53
FIGURE 14HIGH-LEVEL DISINFECTANTS AND TEST STRIPS SEGMENT TO DOMINATE MARKET IN 202153
4.3GEOGRAPHICAL SNAPSHOT OF ENDOSCOPE REPROCESSING MARKET54
FIGURE 15CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD54
5MARKET OVERVIEW55
5.1INTRODUCTION55
5.2MARKET DYNAMICS55
FIGURE 16ENDOSCOPE REPROCESSING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES55
5.2.1DRIVERS56
5.2.1.1Increasing requirement for endoscopy to diagnose
and treat target diseases56
5.2.1.2High risk of endoscope-associated infections56
5.2.1.3Growing geriatric population and subsequent increase
in endoscopic procedures57
5.2.1.4Increasing emphasis on improving reprocessing guidelines
by healthcare authorities58
5.2.1.5Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy59
TABLE 2MAJOR DEVELOPMENTS59
5.2.1.6Increasing preference for minimally invasive surgeries59
5.2.1.7Rising focus of medical specialists and healthcare providers on shifting from manual to automated endoscopy reprocessing60
5.2.2RESTRAINTS61
5.2.2.1Concerns related to reprocessed instrument safety61
5.2.2.2Adverse effects of chemical disinfectants61
5.2.2.3High overhead costs of endoscopy procedures with limited reimbursement in developing countries62
5.2.2.4High risk of COVID-19 transmission during endoscopic procedures62

5.2.3OPPORTUNITIES63
5.2.3.1Growing medical devices industry in emerging economies63
FIGURE 17MEDICAL DEVICES MARKET, 2016-2020 (USD BILLION)64
5.2.4CHALLENGES64
5.2.4.1Preference for single-use endoscopes64
5.2.4.2Increasing number of product failures and recalls65
5.2.4.3Shortage of trained professionals65
5.2.4.4Lack of awareness associated with reprocessing methods66
5.2.4.5Increasing FDA recommended measures to
reduce infection transmission66
5.3COVID-19 IMPACT ANALYSIS67
FIGURE 18PERCENTAGE OF ENDOSCOPY PROCEDURES/PER WEEK
BEFORE AND DURING COVID-1967
5.4RANGES/ SCENARIOS68
5.4.1ENDOSCOPE REPROCESSING MARKET68
FIGURE 19REALISTIC SCENARIO OF ENDOSCOPE REPROCESSING MARKET68
FIGURE 20PESSIMISTIC SCENARIO OF THE ENDOSCOPE REPROCESSING MARKET69
FIGURE 21OPTIMISTIC SCENARIO OF ENDOSCOPE REPROCESSING MARKET69
5.5REGULATORY ANALYSIS70
TABLE 3INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING
MEDICAL DEVICE REPROCESSING70
5.5.1NORTH AMERICA70
5.5.1.1US70
FIGURE 22PREMARKET NOTIFICATION: 510(K) APPROVAL FOR
REPROCESSED MEDICAL DEVICES71
5.5.1.2Canada71
TABLE 4CANADA: REPROCESSING POLICIES OF SINGLE-USE MEDICAL DEVICES72
5.5.2EUROPE73
FIGURE 23CE MARKING FOR REPROCESSED MEDICAL DEVICES73
5.5.2.1Germany73
5.5.2.2Rest of Europe74
5.5.3ASIA PACIFIC74
5.5.3.1Japan74
5.5.3.2Australia74
5.5.3.3Rest of Asia Pacific74
5.5.4LATIN AMERICA75
5.5.5MIDDLE EAST & AFRICA75
5.6PORTER’S FIVE FORCES ANALYSIS75
5.6.1THREAT FROM NEW ENTRANTS76
5.6.2BARGAINING POWER OF SUPPLIERS76
5.6.3BARGAINING POWER OF BUYERS76
5.6.4INTENSITY OF COMPETITIVE RIVALRY76
5.6.5THREAT FROM SUBSTITUTES77
5.7SUPPLY CHAIN ANALYSIS77
FIGURE 24DIRECT DISTRIBUTION—PREFERRED STRATEGY OF PROMINENT COMPANIES78
5.8VALUE CHAIN ANALYSIS78
FIGURE 25VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED
DURING MANUFACTURING AND ASSEMBLY PHASES78
5.9ECOSYSTEM ANALYSIS79
FIGURE 26ENDOSCOPE REPROCESSING MARKET: ECOSYSTEM ANALYSIS79
5.9.1ROLE IN ECOSYSTEM80
FIGURE 27KEY PLAYERS IN ENDOSCOPE REPROCESSING MARKET ECOSYSTEM80
5.10TECHNOLOGY ANALYSIS81
5.11KEY CONFERENCES & EVENTS IN 2022-202382
TABLE 5ENDOSCOPE REPROCESSING MARKET: DETAILED LIST
OF CONFERENCES & EVENTS82
5.12PATENT ANALYSIS83
5.12.1PATENT GRANTED TRENDS FOR ENDOSCOPE REPROCESSORS84
FIGURE 28PATENT GRANTED TRENDS OF AUTOMATED ENDOSCOPE REPROCESSORS, JANUARY 2011– APRIL 202284
FIGURE 29PATENT GRANTED TRENDS OF HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, JANUARY 2011– FEBRUARY 202285
FIGURE 30PATENT GRANTED TRENDS OF ENDOSCOPE TRACKING SYSTEMS, JANUARY 2011– APRIL 202285
5.12.2JURISDICTION AND TOP APPLICANT ANALYSIS86
FIGURE 31TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR AUTOMATED ENDOSCOPE REPROCESSORS PATENTS,
JANUARY 2011—APRIL 202286
FIGURE 32TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, JANUARY 2011—APRIL 202287
FIGURE 33TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ENDOSCOPE TRACKING SYSTEMS, JANUARY 2011— APRIL 202288
5.13TRADE ANALYSIS88
5.13.1IMPORT DATA FOR HS CODE 841920, BY COUNTRY,
2016–2021 (USD MILLION)89
5.13.2EXPORT DATA FOR HS CODE 841920, BY COUNTRY,
2016–2021 (USD MILLION)89
5.13.3EXPORT DATA FOR HS CODE 841920, BY COUNTRY, 2016–202190
5.13.4IMPORT DATA FOR HS CODE 841920, BY COUNTRY, 2016–202190
5.14PRICING ANALYSIS91
TABLE 6AVERAGE SELLING PRICES OF ENDOSCOPE REPROCESSING EQUIPMENT91
TABLE 7AVERAGE SELLING PRICE FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY COUNTRY91
TABLE 8COST OF CONSUMABLES INVOLVED IN REPROCESSING ENDOSCOPES WITH MANUAL CLEANING PLUS AER92
TABLE 9TOTAL ESTIMATED COST FOR REPROCESSING ONE FLEXIBLE ENDOSCOPE93
5.15KEY STAKEHOLDERS & BUYING CRITERIA93
5.15.1KEY STAKEHOLDERS IN BUYING PROCESS93
FIGURE 34INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USERS93
TABLE 10INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USERS (%)94
5.15.2BUYING CRITERIA94
FIGURE 35KEY BUYING CRITERIA FOR END USERS94
TABLE 11KEY BUYING CRITERIA FOR END USERS95
5.16TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES95
5.16.1REVENUE SHIFT & REVENUE POCKETS FOR ENDOSCOPE REPROCESSING MANUFACTURERS95
FIGURE 36REVENUE SHIFT FOR ENDOSCOPE REPROCESSING96
6ENDOSCOPE REPROCESSING MARKET, BY PRODUCT97
6.1INTRODUCTION98
TABLE 12ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)98
TABLE 13ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)99
6.2HIGH-LEVEL DISINFECTANTS AND TEST STRIPS99
6.2.1OUTBREAK OF INFECTIOUS DISEASES TO DRIVE HIGH-LEVEL DISINFECTANTS AND TEST STRIPS DEMAND99
TABLE 14ENDOSCOPE REPROCESSING MARKET FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, BY REGION, 2017–2020 (USD MILLION)100
TABLE 15ENDOSCOPE REPROCESSING MARKET FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, BY REGION, 2021–2027 (USD MILLION)100
6.3DETERGENTS & WIPES101
6.3.1INCREASING EMPHASIS ON PRE-CLEANING METHODS
TO PROPEL SEGMENT GROWTH101
TABLE 16ENDOSCOPE REPROCESSING MARKET DETERGENTS & WIPES,
BY REGION, 2017–2020 (USD MILLION)101
TABLE 17ENDOSCOPE REPROCESSING MARKET FOR DETERGENTS & WIPES,
BY REGION, 2021–2027 (USD MILLION)102
6.4AUTOMATED ENDOSCOPE REPROCESSORS102
6.4.1INCREASED EFFICIENCY OF AUTOMATED ENDOSCOPE REPROCESSORS OVER MANUAL CLEANING TO DRIVE MARKET GROWTH102
TABLE 18MANUFACTURERS AND RESPECTIVE AUTOMATED ENDOSCOPE REPROCESSOR MODELS103
TABLE 19ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY REGION, 2017–2020 (USD MILLION)104
TABLE 20ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY REGION, 2021–2027 (USD MILLION)104
6.4.2AUTOMATED ENDOSCOPE REPROCESSORS, BY PORTABILITY105
6.4.2.1Introduction105
TABLE 21ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY PORTABILITY, 2017–2020 (USD MILLION)105
TABLE 22ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY PORTABILITY, 2021–2027 (USD MILLION)105
6.4.2.2Standalone AER105
TABLE 23ENDOSCOPE REPROCESSING MARKET FOR STANDALONE AER, BY REGION, 2017–2020 (USD MILLION)106
TABLE 24ENDOSCOPE REPROCESSING MARKET FOR STANDALONE AER, BY REGION, 2021–2027 (USD MILLION)106
6.4.2.3Portable AER106
TABLE 25ENDOSCOPE REPROCESSING MARKET FOR PORTABLE AER, BY REGION, 2017–2020 (USD MILLION)107
TABLE 26ENDOSCOPE REPROCESSING MARKET FOR PORTABLE AER, BY REGION, 2021–2027 (USD MILLION)107
6.4.3AUTOMATED ENDOSCOPE REPROCESSORS, BY TYPE107
TABLE 27ENDOSCOPE REPROCESSING MARKET FOR AER, BY TYPE,
2017–2020 (USD MILLION)108
TABLE 28ENDOSCOPE REPROCESSING MARKET FOR AER, BY TYPE,
2021–2027 (USD MILLION)108
6.4.3.1Single-basin AER108
TABLE 29MANUFACTURERS AND RESPECTIVE AER MODELS, BY TYPE (SINGLE BASIN)108
6.4.3.2Double-basin AER109
TABLE 30MANUFACTURERS AND RESPECTIVE AER MODELS, BY TYPE (DUAL BASIN)109
6.5ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS109
6.5.1GUIDELINES FOR DRYING, STORAGE, AND TRANSPORTATION OF REPROCESSED ENDOSCOPES TO DRIVE MARKET GROWTH109
TABLE 31ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS OFFERED110
TABLE 32ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS, BY REGION, 2017–2020 (USD MILLION)111
TABLE 33ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS, BY REGION, 2021–2027 (USD MILLION)111
6.6ENDOSCOPE TRACKING SYSTEMS112
6.6.1RISING FOCUS ON REPROCESSING TO DRIVE SEGMENT GROWTH112
TABLE 34ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE TRACKING SYSTEMS, BY REGION, 2017–2020 (USD MILLION)113
TABLE 35ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE TRACKING SYSTEMS, BY REGION, 2021–2027 (USD MILLION)113
6.7OTHER PRODUCTS114
TABLE 36OTHER PRODUCTS OFFERED BY MANUFACTURERS115
TABLE 37ENDOSCOPE REPROCESSING MARKET FOR OTHER PRODUCTS,
BY REGION, 2017–2020 (USD MILLION)116
TABLE 38ENDOSCOPE REPROCESSING MARKET FOR OTHER PRODUCTS,
BY REGION, 2021–2027 (USD MILLION)116
7ENDOSCOPE REPROCESSING MARKET, BY END USER117
7.1INTRODUCTION118
TABLE 39ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)118
TABLE 40ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)118
7.2HOSPITALS119
7.2.1LARGE PATIENT VOLUME IN HOSPITALS TO INCREASE DEMAND FOR ENDOSCOPE REPROCESSING PRODUCTS119
TABLE 41ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS, BY REGION,
2017–2020 (USD MILLION)120
TABLE 42ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS, BY REGION,
2021–2027 (USD MILLION)120
7.3AMBULATORY SURGERY CENTERS AND CLINICS121
7.3.1COST-EFFECTIVENESS OF AMBULATORY SURGERY CENTERS AND CLINICS TO DRIVE MARKET GROWTH121
TABLE 43NUMBER OF MEDICARE-CERTIFIED AMBULATORY SURGERY
CENTERS IN US, 2013–2017121
TABLE 44TOTAL AMBULATORY SURGERY CENTER PROCEDURES IN US, 2015–2021122
TABLE 45ENDOSCOPE REPROCESSING MARKET FOR AMBULATORY SURGERY CENTERS AND CLINICS, BY REGION, 2017–2020 (USD MILLION)123
TABLE 46ENDOSCOPE REPROCESSING MARKET FOR AMBULATORY SURGERY CENTERS AND CLINICS, BY REGION, 2021–2027 (USD MILLION)123
7.4OTHER END USERS124
TABLE 47ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS,
BY REGION, 2017–2020 (USD MILLION)124
TABLE 48ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS,
BY REGION, 2021–2027 (USD MILLION)125
8ENDOSCOPE REPROCESSING MARKET, BY REGION126
8.1INTRODUCTION127
TABLE 49ENDOSCOPE REPROCESSING MARKET, BY REGION,
2017–2020 (USD MILLION)127
TABLE 50ENDOSCOPE REPROCESSING MARKET, BY REGION,
2021–2027 (USD MILLION)127
8.2NORTH AMERICA128
FIGURE 37NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET SNAPSHOT128
TABLE 51NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2017–2020 (USD MILLION)129
TABLE 52NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2021–2027 (USD MILLION)129
TABLE 53NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)130
TABLE 54NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)130
TABLE 55NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)131
TABLE 56NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)131
TABLE 57NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2017–2020 (USD MILLION)131
TABLE 58NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2021–2027 (USD MILLION)132
8.2.1US132
8.2.1.1Favorable reimbursement scenario to propel market growth132
TABLE 59MEDICARE NATIONAL AVERAGE COVERAGE FOR
OUTPATIENT PROCEDURES, 2021132
TABLE 60US ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)134
TABLE 61US ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)134
TABLE 62US: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)135
TABLE 63US: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)135
TABLE 64US: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)135
TABLE 65US: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)136
8.2.2CANADA136
8.2.2.1High prevalence of hospital-acquired infections to drive market growth136
TABLE 66CANADA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025137
TABLE 67CANADA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)137
TABLE 68CANADA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)138
TABLE 69CANADA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)138
TABLE 70CANADA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)139
TABLE 71CANADA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)139
TABLE 72CANADA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)139
8.3EUROPE140
TABLE 73EUROPE: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,
2017–2020 (USD MILLION)140
TABLE 74EUROPE: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,
2021–2027 (USD MILLION)140
TABLE 75EUROPE ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)141
TABLE 76EUROPE ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)141
TABLE 77EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)142
TABLE 78EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)142
TABLE 79EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)142
TABLE 80EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)143
8.3.1GERMANY143
8.3.1.1Increased surgical procedures to propel market growth143
TABLE 81GERMANY: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025144
TABLE 82GERMANY ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)144
TABLE 83GERMANY ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)145
TABLE 84GERMANY ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)145
TABLE 85GERMANY ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)146
TABLE 86GERMANY ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)146
TABLE 87GERMANY ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)146
8.3.2UK147
8.3.2.1Increasing use of endoscopy procedures to drive market growth147
FIGURE 38MEAN PERCENTAGE CHANGE IN ENDOSCOPE PROCEDURE NUMBERS BETWEEN 2017 AND 2019148
TABLE 88UK: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)149
TABLE 89UK: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)149
TABLE 90UK: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)150
TABLE 91UK: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)150
TABLE 92UK: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)150
TABLE 93UK: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)151
8.3.3FRANCE151
8.3.3.1Increasing prevalence of cancer to support market growth151
TABLE 94FRANCE: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025152
TABLE 95FRANCE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)152
TABLE 96FRANCE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)153
TABLE 97FRANCE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)153
TABLE 98FRANCE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)154
TABLE 99FRANCE: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)154
TABLE 100FRANCE: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)154
8.3.4ITALY155
8.3.4.1Growing geriatric population to support market growth155
TABLE 101ITALY: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025155
TABLE 102ITALY: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)156
TABLE 103ITALY: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)156
TABLE 104ITALY: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)157
TABLE 105ITALY: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)157
TABLE 106ITALY: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)157
TABLE 107ITALY: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)158
8.3.5SPAIN158
8.3.5.1Developing healthcare infrastructure to support market growth158
TABLE 108SPAIN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)159
TABLE 109SPAIN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)159
TABLE 110SPAIN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)160
TABLE 111SPAIN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)160
TABLE 112SPAIN: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)160
TABLE 113SPAIN: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)161
8.3.6REST OF EUROPE161
TABLE 114REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)162
TABLE 115REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)162
TABLE 116REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)163
TABLE 117REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)163
TABLE 118REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)163
TABLE 119REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)164
8.4ASIA PACIFIC164
FIGURE 39ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET SNAPSHOT165
TABLE 120ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,
2017–2020 (USD MILLION)166
TABLE 121ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,
2021–2027 (USD MILLION)166
TABLE 122ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)167
TABLE 123ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)167
TABLE 124ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)168
TABLE 125ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)168
TABLE 126ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)168
TABLE 127ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)169
8.4.1JAPAN169
8.4.1.1Increasing use of endoscopes to drive market growth169
TABLE 128JAPAN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)170
TABLE 129JAPAN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)171
TABLE 130JAPAN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)171
TABLE 131JAPAN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)172
TABLE 132JAPAN: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)172
TABLE 133JAPAN: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)172
8.4.2CHINA173
8.4.2.1Rising prevalence of cancer to increase endoscopic procedures173
TABLE 134CHINA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025173
TABLE 135CHINA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)174
TABLE 136CHINA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)174
TABLE 137CHINA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)175
TABLE 138CHINA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)175
TABLE 139CHINA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)175
TABLE 140CHINA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)176
8.4.3INDIA176
8.4.3.1Developing healthcare infrastructure to support market growth176
TABLE 141INDIA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025177
TABLE 142INDIA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)177
TABLE 143INDIA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)178
TABLE 144INDIA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)178
TABLE 145INDIA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)179
TABLE 146INDIA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)179
TABLE 147INDIA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)179
8.4.4REST OF ASIA PACIFIC180
TABLE 148INCIDENCE OF CANCER IN REST OF ASIA PACIFIC COUNTRIES180
TABLE 149REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)181
TABLE 150REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)181
TABLE 151REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2017–2020 (USD MILLION)182
TABLE 152REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2021–2027 (USD MILLION)182
TABLE 153REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2017–2020 (USD MILLION)182
TABLE 154REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2021–2027 (USD MILLION)183
8.5REST OF THE WORLD183
TABLE 155REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY REGION, 2017–2020 (USD MILLION)183
TABLE 156REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY REGION, 2021–2027 (USD MILLION)184
TABLE 157REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)184
TABLE 158REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)185
TABLE 159REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2017–2020 (USD MILLION)185
TABLE 160REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2021–2027 (USD MILLION)186
TABLE 161REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2017–2020 (USD MILLION)186
TABLE 162REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2021–2027 (USD MILLION)186
8.5.1LATIN AMERICA187
8.5.1.1Rising prevalence of infections due to endoscopy-related procedures to support market growth187
TABLE 163LUNG CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025188
TABLE 164LIVER CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025188
TABLE 165BREAST CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025188
TABLE 166LATIN AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)189
TABLE 167LATIN AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)189
TABLE 168LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)190
TABLE 169LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)190
TABLE 170LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)190
TABLE 171LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)191
8.5.2MIDDLE EAST & AFRICA191
8.5.2.1Introduction of regulatory frameworks for medical equipment reprocessing to drive market growth191
TABLE 172AFRICA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025192
TABLE 173MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET,
BY PRODUCT, 2017–2020 (USD MILLION)192
TABLE 174MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET,
BY PRODUCT, 2021–2027 (USD MILLION)193
TABLE 175MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2017–2020 (USD MILLION)193
TABLE 176MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2021–2027 (USD MILLION)194
TABLE 177MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2017–2020 (USD MILLION)194
TABLE 178MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2021–2027 (USD MILLION)194
9COMPETITIVE LANDSCAPE195
9.1OVERVIEW195
9.2KEY PLAYER STRATEGIES/RIGHT TO WIN195
TABLE 179OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURERS195
9.3REVENUE ANALYSIS196
FIGURE 40REVENUE ANALYSIS OF KEY PLAYERS IN ENDOSCOPE
REPROCESSING MARKET197
9.4MARKET SHARE ANALYSIS197
FIGURE 41ENDOSCOPE REPROCESSING MARKET SHARE ANALYSIS, 2020198
TABLE 180ENDOSCOPE REPROCESSING MARKET: DEGREE OF COMPETITION198
9.5COMPANY EVALUATION QUADRANT (MAJOR PLAYERS)200
9.5.1STARS200
9.5.2EMERGING LEADERS200
9.5.3PERVASIVE PLAYERS200
9.5.4PARTICIPANTS200
FIGURE 42VENDOR DIVE: ENDOSCOPE REPROCESSING MARKET201

9.6COMPETITIVE LEADERSHIP MAPPING (START-UPS AND SMES)202
9.6.1PROGRESSIVE COMPANIES202
9.6.2STARTING BLOCKS202
9.6.3RESPONSIVE COMPANIES202
9.6.4DYNAMIC COMPANIES202
FIGURE 43ENDOSCOPE REPROCESSING MARKET: VENDOR DIVE MATRIX FOR SMES AND START-UPS, 2020203
9.6.4.1COMPETITIVE BENCHMARKING204
TABLE 181ENDOSCOPE REPROCESSING MARKET: DETAILED LIST OF KEY STARTUP/SMES204
TABLE 182ENDOSCOPE REPROCESSING MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS [STARTUPS/SMES]205
9.7COMPANY FOOTPRINT206
TABLE 183COMPANY FOOTPRINT206
TABLE 184COMPANY PRODUCT FOOTPRINT207
TABLE 185COMPANY GEOGRAPHICAL FOOTPRINT208
9.8COMPETITIVE SCENARIO AND TRENDS209
9.8.1DEALS209
TABLE 186DEALS, JANUARY 2019- APRIL 2022209
9.8.2PRODUCT LAUNCHES & APPROVALS210
TABLE 187PRODUCT LAUNCHES & APPROVALS, JANUARY 2019- APRIL 2022210
9.8.3EXPANSIONS211
TABLE 188EXPANSIONS, JANUARY 2019- APRIL 2022211
10COMPANY PROFILES212
10.1KEY PLAYERS212
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
10.1.1CANTEL MEDICAL212
TABLE 189CANTEL MEDICAL: BUSINESS OVERVIEW212
FIGURE 44CANTEL MEDICAL: COMPANY SNAPSHOT (2020)213
10.1.2ADVANCED STERILIZATION PRODUCTS (FORTIVE)217
TABLE 190ADVANCED STERILIZATION PRODUCTS (FORTIVE): BUSINESS OVERVIEW217
FIGURE 45ADVANCED STERILIZATION PRODUCTS (FORTIVE):
COMPANY SNAPSHOT (2020)218
10.1.3OLYMPUS CORPORATION221
TABLE 191OLYMPUS CORPORATION: BUSINESS OVERVIEW221
FIGURE 46OLYMPUS CORPORATION: COMPANY SNAPSHOT (2020)222
10.1.4ECOLAB225
TABLE 192ECOLAB: BUSINESS OVERVIEW225
FIGURE 47ECOLAB: COMPANY SNAPSHOT (2021)226
10.1.5STERIS229
TABLE 193STERIS: BUSINESS OVERVIEW229
FIGURE 48STERIS: COMPANY SNAPSHOT (2020)230
10.1.6GETINGE AB234
TABLE 194GETINGE AB: BUSINESS OVERVIEW234
FIGURE 49GETINGE AB: COMPANY SNAPSHOT (2021)235
10.1.7WASSENBURG MEDICAL (A MEMBER OF HOYA)239
TABLE 195WASSENBURG MEDICAL (A MEMBER OF HOYA): BUSINESS OVERVIEW239
FIGURE 50WASSENBURG MEDICAL (A MEMBER OF HOYA):
COMPANY SNAPSHOT (2020)239
10.1.8CONMED CORPORATION241
TABLE 196CONMED CORPORATION: BUSINESS OVERVIEW241
FIGURE 51CONMED CORPORATION: COMPANY SNAPSHOT (2021)242
10.1.9BELIMED AG (A METALL ZUG GROUP COMPANY)243
TABLE 197BELIMED AG (METALL ZUG GROUP COMPANY): BUSINESS OVERVIEW243
FIGURE 52BELIMED AG (METALL ZUG GROUP COMPANY): COMPANY SNAPSHOT (2021)244
10.1.10ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL)246
TABLE 198ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL): BUSINESS OVERVIEW246
FIGURE 53ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL):
COMPANY SNAPSHOT (2020)246
10.1.11CUSTOM ULTRASONICS249
TABLE 199CUSTOM ULTRASONICS: BUSINESS OVERVIEW249
10.1.12STEELCO S.P.A250
TABLE 200STEELCO S.P.A: BUSINESS OVERVIEW250
10.1.13BES HEALTHCARE (A DIVISION OF BES REHAB LTD)252
TABLE 201BES HEALTHCARE: BUSINESS OVERVIEW252
10.1.14ARC HEALTHCARE SOLUTIONS253
TABLE 202ARC HEALTHCARE SOLUTIONS: BUSINESS OVERVIEW253
10.1.15METREX RESEARCH, LLC254
TABLE 203METREX RESEARCH. LLC: BUSINESS OVERVIEW254
10.2OTHER PLAYERS255
10.2.1RICHARD

Report Title: Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 - 2027)


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Global Orphan Cancer Drug Market, Drug Sales, Price & Clinical Trials Insight 2028

Global Orphan Cancer Drug Market, Drug Sales, Price & Clinical Trials Insight 2028

United Kingdom Restorative Dentistry Market, By Type (Anterior v/s Posterior), By Restoration Type (Direct v/s Indirect), By Product (Restorative Materials, Implants, Prosthetics, Restorative Equipment, Others), By End User (Hospitals & Clinics, Dental Laboratories, Others), By Region, Competition Forecast & Opportunities, 2027

United Kingdom Restorative Dentistry Market, By Type (Anterior v/s Posterior), By Restoration Type (Direct v/s Indirect), By Product (Restorative Materials, Implants, Prosthetics, Restorative Equipment, Others), By End User (Hospitals & Clinics, Dental Laboratories, Others), By Region, Competition Forecast & Opportunities, 2027

United Kingdom Renal Denervation Market, By Technology (Ultrasound Ablation, Radiofrequency Ablation, Pharmacologic Ablation, Micro-infusion), By Product (Catheters, Single Electrode Catheter, Multi Electrode Catheter, RF Generator, Others), By Therapeutic Area (Hypertension, Heart Failure, Diabetes, Renal Failure, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region, Competition Forecast & Opportunities, 2027

United Kingdom Renal Denervation Market, By Technology (Ultrasound Ablation, Radiofrequency Ablation, Pharmacologic Ablation, Micro-infusion), By Product (Catheters, Single Electrode Catheter, Multi Electrode Catheter, RF Generator, Others), By Therapeutic Area (Hypertension, Heart Failure, Diabetes, Renal Failure, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region, Competition Forecast & Opportunities, 2027

United Kingdom Oral Care Market, By Type (Toothpaste, Toothbrush, Mouthwashes/Rinses, Dental Accessories, Denture Products, Others), By Distribution Channel (Consumer Stores, Retail Pharmacies, Online Distribution, Dental Dispensaries), By End User (Dental Hospitals & Clinics v/s Homecare), By Region, Competition Forecast & Opportunities, 2027

United Kingdom Oral Care Market, By Type (Toothpaste, Toothbrush, Mouthwashes/Rinses, Dental Accessories, Denture Products, Others), By Distribution Channel (Consumer Stores, Retail Pharmacies, Online Distribution, Dental Dispensaries), By End User (Dental Hospitals & Clinics v/s Homecare), By Region, Competition Forecast & Opportunities, 2027

United Kingdom Medical Loupes Market, By Type (Flip-Up Loupes, Through-The-Lens (TTL) Loupes, Clip-On Loupes, Headband Mounted), By Lens Type (Galilean v/s Prismatic), By Distribution Channel (Offline v/s Online), By Application (Surgical, Dental, Others), By End User (Hospitals, Dental Clinics, Ambulatory Surgery Centers, Others), By Source (Domestic v/s Import), By Region, Competition Forecast & Opportunities, 2027

United Kingdom Medical Loupes Market, By Type (Flip-Up Loupes, Through-The-Lens (TTL) Loupes, Clip-On Loupes, Headband Mounted), By Lens Type (Galilean v/s Prismatic), By Distribution Channel (Offline v/s Online), By Application (Surgical, Dental, Others), By End User (Hospitals, Dental Clinics, Ambulatory Surgery Centers, Others), By Source (Domestic v/s Import), By Region, Competition Forecast & Opportunities, 2027

United Kingdom Glucometers Market, By Product Type (Self Glucose Monitoring Glucometers v/s Continuous Glucose Monitoring Glucometers), By Technique (Invasive v/s Non-Invasive), By Type (Wearable v/s Non-Wearable), By Distribution Channel (Hospital Pharmacies, Retail Outlet, Online, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Home Care, Others), By Region, Competition Forecast & Opportunities, 2027

United Kingdom Glucometers Market, By Product Type (Self Glucose Monitoring Glucometers v/s Continuous Glucose Monitoring Glucometers), By Technique (Invasive v/s Non-Invasive), By Type (Wearable v/s Non-Wearable), By Distribution Channel (Hospital Pharmacies, Retail Outlet, Online, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Home Care, Others), By Region, Competition Forecast & Opportunities, 2027